Arjo AB (FRA:A39) Construction In Progress: €0.0 Mil (As of Mar. 2026)


FRA:A39 Arjo AB FRA:A39
73 GF Score
Price €2.21
GF Value €3.27
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is Arjo AB Construction In Progress?

Arjo AB FRA:A39 +1.10% 73 Construction In Progress is €0.0 Mil as of Mar. 2026. GuruFocus rates FRA:A39 with a GF Score™ of 73/100 and a GF Value™ of €3.27 (Significantly Undervalued). The stock has 5 warning signs investors should review.

Arjo AB's quarterly construction in progress increased from Sep. 2025 (€0.0 Mil) to Dec. 2025 (€4.4 Mil) but then declined from Dec. 2025 (€4.4 Mil) to Mar. 2026 (€0.0 Mil).

Arjo AB's annual construction in progress increased from Dec. 2023 (€6.1 Mil) to Dec. 2024 (€7.7 Mil) but then declined from Dec. 2024 (€7.7 Mil) to Dec. 2025 (€4.4 Mil).

Arjo AB Construction In Progress Historical Data

* Premium members only.

The historical data trend for Arjo AB's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Arjo AB Construction In Progress Chart

Arjo AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 9.46 6.08 7.65 4.41

Arjo AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 4.41 0.00
FRA:A39
73GF Score
Arjo AB FRA:A39
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Arjo AB Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of €0.0 Mil mean?
Arjo AB (FRA:A39) has a Construction In Progress of €0.0 Mil as of Mar. 2026. Construction in Progress records the amount of construction work that is not complete. View historical data on Arjo AB and its competitors.
Is Arjo AB's Construction In Progress too high?
Arjo AB's current Construction In Progress is €0.0 Mil. Overall, Arjo AB has a GF Score™ of 73/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Arjo AB's Construction In Progress compare to MCK and CAH?
Arjo AB's Construction In Progress of €0.0 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Medical Distribution company?
A good Construction In Progress depends on the Medical Distribution industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on Arjo AB and its competitors. Arjo AB's current Construction In Progress is €0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arjo AB stock overvalued right now?
Based on GuruFocus' analysis, Arjo AB (FRA:A39) is currently considered Significantly Undervalued. The stock's GF Value™ is €3.27, compared to a current price of €2.21 — trading 32.4% below its estimated fair value. The current Construction In Progress is €0.0 Mil. Arjo AB's overall GF Score™ is 73/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For Arjo AB (FRA:A39), the current Construction In Progress is €0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Arjo AB (FRA:A39) Overvalued in 2026?

Based on GuruFocus' analysis, Arjo AB stock appears to be undervalued. The current stock price of €2.21 is trading 32.4% below its estimated GF Value™ of €3.27. GuruFocus considers Arjo AB to be Significantly Undervalued.

Key valuation signals for FRA:A39:

  • Construction In Progress: €0.0 Mil
  • GF Value™: €3.27 vs. price of €2.21 (32.4% below fair value)
  • GF Score™: 73/100 with 5 warning signs

No single metric tells the full story. See the FRA:A39 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Arjo AB Business Description

Address Hans Michelsensgatan 10, Box 48, Malmo, SWE, SE-201 20
Arjo AB is a supplier of medical devices, services, and solutions in Sweden. It serves its services to private and public institutions with acute care and long-term care. The company's offering includes products and solutions for patient handling, hygiene, disinfection, medical beds, therapeutic surfaces, venous thromboembolism (VTE) prevention and diagnostics. The company includes segments: Global Sales, North America, Diagnostics.
73GF Score

Get the complete analysis for FRA:A39

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.21
Price
€3.27
GF Value